Kobayashi T, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74.
Article
Google Scholar
Shah SC, et al. Sex-based differences in incidence of inflammatory bowel diseases—pooled analysis of population-based studies from western countries. Gastroenterology. 2018;155(4):1079-1089.e3.
Article
Google Scholar
Vanuytsel T, Vermeire S, Cleynen I. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers. 2013;1(5):e27321.
Article
Google Scholar
Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3(7):521–33.
Article
CAS
Google Scholar
Loftus EV Jr. Update on the incidence and prevalence of inflammatory bowel disease in the United States. Gastroenterol Hepatol. 2016;12(11):704–7.
Google Scholar
Molodecky, N.A., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 2012;142(1):46–54.e42; quiz e30.
Michielan, A., D'Incà, R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015;2015:628157.
Madsen KL, et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5(4):262–70.
Article
CAS
Google Scholar
Wyatt J, et al. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet. 1993;341(8858):1437–9.
Article
CAS
Google Scholar
Teshima CW, Dieleman LA, Meddings JB. Abnormal intestinal permeability in Crohn’s disease pathogenesis. Ann N Y Acad Sci. 2012;1258:159–65.
Article
CAS
Google Scholar
Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk. Gastroenterology. 2000;119(6):1740–4.
Article
CAS
Google Scholar
Fasano A, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518–9.
Article
CAS
Google Scholar
El Asmar R, et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 2002;123(5):1607–15.
Article
Google Scholar
Tripathi A, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA. 2009;106(39):16799–804.
Article
CAS
Google Scholar
Fasano A. Zonulin measurement conundrum: add confusion to confusion does not lead to clarity. Gut. 2021;70(10):2007–8.
Article
Google Scholar
Szymanska E, Wierzbicka A, Dadalski M, Kierkus J. Fecal Zonulin as a noninvasive biomarker of intestinal permeability in pediatric patients with inflammatory bowel diseases—correlation with disease activity and fecal calprotectin. J Clin Med. 2021;10(17):3905.
Article
CAS
Google Scholar
Fasano, A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res. 2020:9.
Mokkala K, et al. Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women. Metabolism. 2017;69:43–50.
Article
CAS
Google Scholar
Ciccia F, et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis. 2017;76(6):1123–32.
Article
CAS
Google Scholar
Li C, et al. Zonulin regulates intestinal permeability and facilitates enteric bacteria permeation in coronary artery disease. Sci Rep. 2016;6:29142.
Article
CAS
Google Scholar
Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol. 2012;10(10):1096–100.
Article
CAS
Google Scholar
de Kort S, Keszthelyi D, Masclee AAM. Leaky gut and diabetes mellitus: what is the link? Obes Rev 2011;12(6)(1467–789X (Electronic)).
Ohlsson L, et al. Leaky gut biomarkers in depression and suicidal behavior. Acta Psychiatr Scand. 2019;139(2):185–93.
Article
CAS
Google Scholar
Samsioe G, et al. The women’s health in the Lund area (WHILA) study–an overview. Maturitas. 2010;65(1):37–45.
Article
Google Scholar
Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151–75.
Article
CAS
Google Scholar
Hasslacher C, Kulozik F, Platten I, Kraft M, Siegel EG. Serum zonulin as parameter of intestinal permeability in longstanding type 2 diabetes: correlations with metabolism parameter and renal function. J Diabetes Metab Disord Control. 2018;5(2):58–62.
Article
Google Scholar
Ohlsson B, Orho-Melander M, Nilsson PM. Higher levels of serum Zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations. Int J Mol Sci. 2017;18(3):582.
Article
Google Scholar
Rahmani J, et al. Body mass index and risk of inflammatory bowel disease: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. Obes Rev. 2019;20(9):1312–20.
Article
Google Scholar
Benjamin JL, et al. Smokers with active Crohn’s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis. 2012;18(6):1092–100.
Article
Google Scholar
Kim AS, Ko H-J. Plasma concentrations of zonulin are elevated in obese men with fatty liver disease. Diabetes Metab Syndr Obes. 2018;11:149–57.
Article
Google Scholar
Swanson GR, et al. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol (Fayetteville, NY). 2010;44(3):223–8.
Article
CAS
Google Scholar
Fasano A. Intestinal zonulin: open sesame! Gut. 2001;49(2):159–62.
Article
CAS
Google Scholar
Caviglia GP, et al. Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva Med. 2019;110(2):95–100.
Article
Google Scholar
Malíčková K, et al. Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers. Practical laboratory medicine. 2017;9:39–44.
Article
Google Scholar
Wood Heickman LK, DeBoer MD, Fasano A. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes Metab Res Rev. 2020;e3309.
Zhang D, et al. Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. Eur J Endocrinol. 2015;172(1):29–36.
Article
CAS
Google Scholar
Jayashree B, et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem. 2014;388(1–2):203–10.
Article
CAS
Google Scholar
Leech B, et al. Risk factors associated with intestinal permeability in an adult population: a systematic review. Int J Clin Pract. 2019;73(10):e13385.
Article
Google Scholar
Sappati Biyyani RS, Putka BS, Mullen KD. Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease. J Clin Lipidol. 2010;4(6):478–82.
Article
Google Scholar
Scheffler L, et al. Widely used commercial ELISA does not detect precursor of Haptoglobin2, but recognizes properdin as a potential second member of the Zonulin family. Front Endocrinol (Lausanne). 2018;9:22.
Article
Google Scholar
Ajamian M, et al. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS ONE. 2019;14(1):e0210728–e0210728.
Article
CAS
Google Scholar